Teresa Dawn
Teresa Dawn
Stop FollowingTeresa Dawn
View as an RSS Feed
- Companies Developing Targeted Cancer Treatments Seek Higher Profits In 2013
- 3 Immunotherapy Companies That Have Learned Their Lessons Well
- The Volume Theory: Determining Which Stocks May Continue To Trade Higher
- Is Celldex Worth The Risk In 2013?
- 4 Companies With High Upside And Large Short Interest
- Investing Near All-Time Highs
- Pfizer And Eli Lilly Sit At New Highs; Which Is The Better Buy?
- Is SodaStream Preparing To Reverse?
- 3 Small Cap Movers With Similar Trends But Different Outlooks
- Nordion Continues To Prepare Investors For A New-Look Company
- 2013: The Year Of The Airlines?
- 3 Bright Spots In A Fragile Retail Industry
